Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Lipid cross-linking of nanolipoprotein particles substantially enhances serum stability and cellular uptake [Lipid crosslinking enhances the stability of nanolipoprotein particles in serum by multiple orders of magnitude]

Journal Article · · ACS Applied Materials and Interfaces
 [1];  [1];  [2];  [3];  [1];  [1];  [2];  [1];  [2]
  1. Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States). Biosciences and Biotechnology Division
  2. Univ. of California, Davis, CA (United States). UC Davis Comprehensive Cancer Center, Dept. of Internal Medicine and Division of Hematology and Oncology
  3. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Life Science Division; Univ. of California, Santa Cruz, CA (United States). Dept. of Chemistry and Biochemistry
Nanolipoprotein particles (NLPs) consist of a discoidal phospholipid lipid bilayer confined by an apolipoprotein belt. NLPs are a promising platform for a variety of biomedical applications due to their biocompatibility, size, definable composition, and amphipathic characteristics. However, poor serum stability hampers the use of NLPs for in vivo applications such as drug formulation. In this study, NLP stability was enhanced upon the incorporation and subsequent UV-mediated intermolecular cross-linking of photoactive DiynePC phospholipids in the lipid bilayer, forming cross-linked nanoparticles (X-NLPs). Both the concentration of DiynePC in the bilayer and UV exposure time significantly affected the resulting X-NLP stability in 100% serum, as assessed by size exclusion chromatography (SEC) of fluorescently labeled particles. Cross-linking did not significantly impact the size of X-NLPs as determined by dynamic light scattering and SEC. X-NLPs had essentially no degradation over 48 h in 100% serum, which is a drastic improvement compared to non-cross-linked NLPs (50% degradation by ~10 min). X-NLPs had greater uptake into the human ATCC 5637 bladder cancer cell line compared to non-cross-linked particles, indicating their potential utility for targeted drug delivery. X-NLPs also exhibited enhanced stability following intravenous administration in mice. Lastly, these results collectively support the potential utility of X-NLPs for a variety of in vivo applications.
Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States); Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
Sponsoring Organization:
National Inst. of Health (NIH); USDOE Office of Science (SC), Biological and Environmental Research (BER) (SC-23)
Grant/Contract Number:
AC02-05CH11231; AC52-07NA27344
OSTI ID:
1342026
Alternate ID(s):
OSTI ID: 1440936
Report Number(s):
LLNL-JRNL--683565
Journal Information:
ACS Applied Materials and Interfaces, Journal Name: ACS Applied Materials and Interfaces Journal Issue: 32 Vol. 8; ISSN 1944-8244
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
English

References (50)

Targeted Delivery of Amphotericin B to Cells by Using Functionalized Carbon Nanotubes journal October 2005
Preparation, Characterizations, and In Vitro Metabolic Processes of Paclitaxel-Loaded Discoidal Recombinant High-Density Lipoproteins journal August 2012
Assembly of anthrax toxin pore: Lethal-factor complexes into lipid nanodiscs: Assembly of Anthrax Toxin Pore: Lethal Factor Complexes journal February 2013
HDL‐Mimicking Peptide–Lipid Nanoparticles with Improved Tumor Targeting journal January 2010
Cell-Free Expression for Nanolipoprotein Particles: Building a High-Throughput Membrane Protein Solubility Platform book January 2009
High-Throughput SAXS for the Characterization of Biomolecules in Solution: A Practical Approach book October 2013
Phospholipid polymers—Synthesis and spectral characteristics journal October 1980
Biotinyl-high-density lipoproteins as a probe for the determination of high-density lipoprotein turnover in humans journal April 1990
The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments. journal October 1983
Metabolic fate of rat and human lipoprotein apoproteins in the rat journal July 1973
Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting journal April 2001
Virus-based nanoparticles (VNPs): Platform technologies for diagnostic imaging☆ journal December 2006
Effect of phospholipid composition on discoidal HDL formation journal May 2013
LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma journal December 2013
The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge journal December 2013
A novel composite immunotoxin that suppresses rabies virus production by the infected cells journal February 2010
Peptide stabilized amphotericin B nanodisks journal April 2007
X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution journal August 2007
Isolation of Monodisperse Nanodisc-Reconstituted Membrane Proteins Using Free Flow Electrophoresis journal March 2013
Conjugation to Nickel-Chelating Nanolipoprotein Particles Increases the Potency and Efficacy of Subunit Vaccines to Prevent West Nile Encephalitis journal June 2010
Kinetic Analysis of His-Tagged Protein Binding to Nickel-Chelating Nanolipoprotein Particles journal July 2010
Polymerized liposomes formed under extremely mild conditions journal November 1986
Different Apolipoproteins Impact Nanolipoprotein Particle Formation
  • Chromy, Brett A.; Arroyo, Erin; Blanchette, Craig D.
  • Journal of the American Chemical Society, Vol. 129, Issue 46, p. 14348-14354 https://doi.org/10.1021/ja074753y
journal November 2007
Elliptical Structure of Phospholipid Bilayer Nanodiscs Encapsulated by Scaffold Proteins: Casting the Roles of the Lipids and the Protein journal October 2010
Colocalized Delivery of Adjuvant and Antigen Using Nanolipoprotein Particles Enhances the Immune Response to Recombinant Antigens journal January 2013
Characterizing the Membrane-Bound State of Cytochrome P450 3A4: Structure, Depth of Insertion, and Orientation journal May 2013
Synthesis and in Vivo Antitumor Activity of Poly( l -glutamic acid) Conjugates of 20( S )-Camptothecin journal January 2003
Cross-Linkable Liposomes Stabilize a Magnetic Resonance Contrast-Enhancing Polymeric Fastener journal March 2014
Polymerized Lipid Bilayers on a Solid Substrate: Morphologies and Obstruction of Lateral Diffusion journal December 2008
Phase Separation of Lipid Microdomains Controlled by Polymerized Lipid Bilayer Matrices journal December 2009
Stability of Self-Assembled Polymeric Micelles in Serum journal August 2011
Robust, high-throughput solution structural analyses by small angle X-ray scattering (SAXS) journal July 2009
Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma journal February 2015
Monitoring Shifts in the Conformation Equilibrium of the Membrane Protein Cytochrome P450 Reductase (POR) in Nanodiscs* journal October 2012
Cell-free Co-expression of Functional Membrane Proteins and Apolipoprotein, Forming Soluble Nanolipoprotein Particles journal July 2008
LDL Receptor: An open route to feed pancreatic tumor cells journal February 2015
Dendrimer-platinate: a novel approach to cancer chemotherapy journal January 1999
Implementation and performance of SIBYLS: a dual endstation small-angle X-ray scattering and macromolecular crystallography beamline at the Advanced Light Source journal January 2013
WillItFit : a framework for fitting of constrained models to small-angle scattering data journal November 2013
Software for the high-throughput collection of SAXS data using an enhanced Blu-Ice / DCS control system journal September 2010
Drug Delivery Systems: Entering the Mainstream journal March 2004
High-Resolution Imaging of Dendrimers Used in Drug Delivery via Scanning Probe Microscopy journal June 2011
Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies journal June 2004
Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol) journal June 2005
Therapeutic Nanoparticles for Drug Delivery in Cancer journal March 2008
Quantifying size distributions of nanolipoprotein particles with single-particle analysis and molecular dynamic simulations journal April 2008
Isolation, Characterization, and Stability of Discretely-Sized Nanolipoprotein Particles Assembled with Apolipophorin-III journal July 2010
Characterization of De Novo Synthesized GPCRs Supported in Nanolipoprotein Discs journal September 2012
Evaluation of Nanolipoprotein Particles (NLPs) as an In Vivo Delivery Platform journal March 2014
Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer journal December 2003

Cited By (3)

Towards Utilising Photocrosslinking of Polydiacetylenes for the Preparation of “Stealth” Upconverting Nanoparticles journal October 2018
Towards Utilising Photocrosslinking of Polydiacetylenes for the Preparation of “Stealth” Upconverting Nanoparticles journal December 2018
Lipid composition dictates serum stability of reconstituted high-density lipoproteins: implications for in vivo applications journal January 2018